"The solid financial footing also has Genmab on the acquisition hunt to further bolster the portfolio, specifically in search of molecules in later stages of development."
Could be a potential suitor. Link to article below -
Genmab's growth plan entails partnering less, owning more: CEO (fiercebiotech.com)
- Forums
- ASX - By Stock
- PAB
- Ann: Presentation to highlight broader potential of Deoxymabs
Ann: Presentation to highlight broader potential of Deoxymabs, page-12
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 63225 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 63226 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 63225 | 0.008 |
17 | 4746691 | 0.007 |
12 | 2704182 | 0.006 |
9 | 3859992 | 0.005 |
6 | 4299000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 63226 | 1 |
0.008 | 873528 | 6 |
0.009 | 1358703 | 2 |
0.010 | 306000 | 3 |
0.011 | 1780000 | 4 |
Last trade - 09.08am 14/06/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable